Oral prostate cancer therapy is taken at home, every day. The support around it should not stop at your office door.
Oral prostate cancer agents like Xtandi, Zytiga, Erleada, and Nubeqa are taken at home, where prior authorizations, cost, side effects, and daily adherence all sit on the patient. Fairview Pharmacy dispenses locally, handles the prior authorization process, navigates financial assistance, and verifies adherence, so the therapy you prescribe stays supported.
What the patient is carrying at home
Once an oral prostate cancer agent leaves your office, the logistics become the patient's problem.
An oral oncolytic can carry a prior authorization that takes time to clear, an out of pocket cost that stops a patient cold, side effects managed alone at home, and a daily dosing schedule with no observation. When the prescription is routed to a distant mail order pharmacy, you lose visibility into all of it.
Fairview dispenses locally and stays involved: prior authorization worked, financial assistance navigated, adherence verified, and contact maintained with the patient.
What a specialty capable pharmacy does
Prior authorization, financial navigation, adherence verification.
Prior authorization
We manage and appeal the prior authorization process for oral prostate cancer agents, so the workload does not sit on your staff and the patient does not wait longer than necessary.
Financial toxicity support
We help patients identify and apply for manufacturer copay assistance and foundation grants, so cost is less likely to interrupt therapy.
Daily adherence verification
We confirm the prescription is started and taken on schedule, and we synchronize refills.
Side effect check ins
We call between refills to catch fatigue and side effects early, before they become a reason to stop.
Communication back to you
We flag adherence concerns and barriers back to your office, so you are not the last to know when a patient is struggling to stay on therapy.
This page describes pharmacy services: prior authorization, financial navigation, and adherence support. The clinical care is yours; the medication logistics are where Fairview helps.
The visibility you lose to mail order
When an oral oncolytic is routed to a distant mail order pharmacy, you lose visibility.
Nobody confirms the patient started. Nobody catches a skipped refill. Nobody calls when cost has become the reason they stopped. The patient may never tell you; they just fall off therapy quietly. You learn at the next PSA.
A local, specialty capable pharmacy closes that gap. Fairview dispenses here, in Hattiesburg, and stays in contact.
EQuIPP verified, all four measures published
Fairview is a measured, high performing pharmacy. We bring that rigor to oncology support.
EQuIPP star measures, Elevate Provider Network. Quarter 4, 2025, closed measurement year.
- Blood pressure (RASA) PDC98.2%, 215 of 219 patients5 stars
- Cholesterol PDC97.2%, 246 of 253 patients5 stars
- Statin use in diabetes96.3%, 52 of 54 patients5 stars
- Diabetes PDC95.6%, 108 of 113 patients5 stars
EQuIPP star rating 5.00. Five stars on all four measures, every year since 2022.
Fairview's EQuIPP star measure performance, issued by Elevate Provider Network for the closed 2025 measurement year: Blood pressure (RASA) PDC 98.2%, 215 of 219 patients. Cholesterol PDC 97.2%, 246 of 253. Statin use in diabetes 96.3%, 52 of 54. Diabetes PDC 95.6%, 108 of 113. EQuIPP star rating 5.00. Five stars on all four measures, every year since 2022. We apply the same rigor to oral prostate cancer therapy support: prior authorization worked and appealed promptly, financial barriers navigated, adherence verified, contact maintained.
EQuIPP performance metrics as of Quarter 4, 2025, Medicare Part D population, benchmarked against national pharmacy averages. These measures describe prescribing and dispensing patterns. Neither is a measure of health outcomes.
You prescribe.
E prescribe to Fairview. NCPDP 2515104, NPI 1144383613.
We fill and resolve.
We resolve every prior authorization.
We verify adherence.
We confirm the prescription is taken on schedule and call between refills.
We report to you.
Adherence and refill updates on the patients you referred.
You reinforce.
You address adherence at the next visit.
Local same day dispensing
Oral oncolytics filled here, not mailed from out of state.
100% prior authorization handling
We manage and appeal every prior authorization for you.
Daily adherence verification
We confirm every prescription is started and taken on schedule.
Financial toxicity support
We find copay assistance and foundation grants before cost interrupts therapy.
Side effect check ins
We call between refills to catch side effects early.
Adherence reports to you
Refill by refill adherence delivered to your office.
Start with 5, zero risk
Send us 5 of your patients on oral prostate cancer therapy. 90 days. Zero risk.
We handle the prior authorizations, verify adherence, and report back to your office. No contract, no cost, and nothing owed in either direction. If the reports are not useful, tell us and we will change the format.
Request your intro call
A 10 minute call with Dr. Mike, no commitment and no paperwork to start. Just tell us how to reach you and a little about your practice. The 5 patient pilot is what we walk through on the call.
Typical response: Within 1 business day
Forms for referring practices